Bio-Rad Laboratories (BIO) earnings

Earnings (net income) · fiscal 2025
$759.90M

Bio-Rad Laboratories (BIO) reported net income of $759.90M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.84B. Figures as of 18 Nov 2026, 08:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$759.90M
Growth, 5 years
−27.6% a year
Growth, 10 years
+21.4% a year
Highest on record
$4.25Bfiscal 2021
Lowest on record
-$3.63Bfiscal 2022
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Rad Laboratories earnings, in more detail

Over the five fiscal years to 2025 net income shrank at a compound 27.6% a year; over ten years the rate was 21.4% a year. Across the 18 fiscal years on record (2008–2025), the highest was $4.25B in fiscal 2021 and the lowest -$3.63B in fiscal 2022.

History · 18 fiscal years

Earnings (net income) by fiscal year

Bio-Rad Laboratories earnings, year by year

Bio-Rad Laboratories (BIO) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$759.90M—
2024-$1.84B—
2023-$637.30M—
2022-$3.63B 185.3% down
2021$4.25B 11.5% up
2020$3.81B 116.9% up
2019$1.76B 381.0% up
2018$365.61M 199.1% up
2017$122.25M 370.2% up
2016$26.00M 76.2% down
2015$109.24M 23.0% up
2014$88.85M 14.2% up
2013$77.79M 53.0% down
2012$165.48M 7.6% down
2011$179.01M 3.5% down
2010$185.49M 28.3% up
2009$144.62M 61.6% up
2008$89.51M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Bio-Rad Laboratories and comparable companies
CompanyEarnings (net income)Fiscal year
Ensign Group ENSG$343.97M2025
Vaxcyte PCVX-$766.63M2025
Bio-Rad Laboratories BIO$759.90M2025
Molina Healthcare MOH$472.00M2025
Spyre Therapeutics SYRE-$155.20M2025
Qiagen QGEN$424.88M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIO

Bio-Rad Laboratories, figure by figure

Bio-Rad Laboratories (BIO) overview: price, valuation and scorecardAll health care companies by market value

Bio-Rad Laboratories earnings: questions and answers

What is Bio-Rad Laboratories's net income?

Bio-Rad Laboratories (BIO) reported net income of $759.90M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.84B.

What is the growth rate of Bio-Rad Laboratories's net income?

Over the five fiscal years to 2025 net income shrank at a compound 27.6% a year; over ten years the rate was 21.4% a year.

What are the highest and lowest net income figures on record for Bio-Rad Laboratories?

Across the 18 fiscal years on record (2008–2025), the highest was $4.25B in fiscal 2021 and the lowest -$3.63B in fiscal 2022.

How is Bio-Rad Laboratories's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Rad Laboratories (BIO) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/BIO/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.